N.M. Admin. Code § 8.321.10.24 - WITHDRAWAL TREATMENT AND MEDICALLY SUPERVISED DOSE REDUCTION
The
A. policies and procedures are developed,
implemented, and complied with for withdrawal treatment and:
(1) are designed to promote successful
withdrawal treatment;
(2) require
that dose reduction occur at a rate deemed medically appropriate by the program
medical director ;
(3) require that
a variety of ancillary services, such as self-help groups, be available to the
patient through the program or through referral;
(4) require that the amount of counseling
available to the patient be increased before discharge; and
(5) require that a patient be re-admitted to
the program or referred to another program if relapse occurs;
B. a patient's withdrawal
treatment:
(1) for a patient involved in
comprehensive maintenance treatment , is only initiated as administrative
withdrawal , or when voluntarily requested by the patient and approved by a
program medical director ; and
(2)
is planned and supervised by the program medical director ;
C. before a patient begins withdrawal
treatment, whether with or against the advice of the program medical director ,
the patient:
(1) is informed by the program
medical director or a medical practitioner designee:
(a) that the patient has the right to leave
opioid treatment at any time; and
(b) of the risks of withdrawal treatment;
and
(2) upon request,
receives a schedule for withdrawal treatment that is developed by the program
medical director with input from the patient;
(3) receives a copy of the program policy
regarding withdrawal of opioid medication against medical advice and a verbal
explanation of that policy ;
D. if a patient who is receiving withdrawal
treatment, other than a patient experiencing administrative withdrawal , appears
to a staff member to relapse, the patient is permitted to begin comprehensive
maintenance treatment , if otherwise eligible;
E. if a patient who has completed withdrawal
treatment within the past 30 days appears to a staff member to relapse, the
patient may be re-admitted without a physical examination or assessment with
the consent of the program medical director ;
F. a patient experiencing administrative
withdrawal is referred or transferred to any program that is capable of or more
suitable for meeting the patient's needs, and the referral or transfer is
documented in the patient record;
G. the following information is documented in
the patient record:
(1) the reason that the
patient sought withdrawal treatment or was placed on administrative withdrawal ;
and
(2) the information and
assistance provided to the patient in medical withdrawal or administrative
withdrawal .
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
The program sponsor shall ensure that:
A. policies and procedures are developed, implemented, and complied with for withdrawal treatment and:
(1) are designed to promote successful withdrawal treatment;
(2) require that dose reduction occur at a rate deemed medically appropriate by the program medical director;
(3) require that a variety of ancillary services, such as self-help groups, be available to the patient through the program or through referral;
(4) require that the amount of counseling available to the patient be increased before discharge; and
(5) require that a patient be re-admitted to the program or referred to another program if relapse occurs;
B. a patient's withdrawal treatment:
(1) for a patient involved in comprehensive maintenance treatment, is only initiated as administrative withdrawal, or when voluntarily requested by the patient and approved by a program medical director; and
(2) is planned and supervised by the program medical director;
C. before a patient begins withdrawal treatment, whether with or against the advice of the program medical director, the patient:
(1) is informed by the program medical director or a medical practitioner designee:
(a) that the patient has the right to leave opioid treatment at any time; and
(b) of the risks of withdrawal treatment; and
(2) upon request, receives a schedule for withdrawal treatment that is developed by the program medical director with input from the patient;
(3) receives a copy of the program policy regarding withdrawal of opioid medication against medical advice and a verbal explanation of that policy;
D. if a patient who is receiving withdrawal treatment, other than a patient experiencing administrative withdrawal, appears to a staff member to relapse, the patient is permitted to begin comprehensive maintenance treatment, if otherwise eligible;
E. if a patient who has completed withdrawal treatment within the past 30 days appears to a staff member to relapse, the patient may be re-admitted without a physical examination or assessment with the consent of the program medical director;
F. a patient experiencing administrative withdrawal is referred or transferred to any program that is capable of or more suitable for meeting the patient's needs, and the referral or transfer is documented in the patient record;
G. the following information is documented in the patient record:
(1) the reason that the patient sought withdrawal treatment or was placed on administrative withdrawal; and
(2) the information and assistance provided to the patient in medical withdrawal or administrative withdrawal.